GDS Wealth Management Raises Stock Position in HealthEquity, Inc. $HQY

GDS Wealth Management grew its stake in HealthEquity, Inc. (NASDAQ:HQY) by 15.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,969 shares of the company’s stock after purchasing an additional 13,682 shares during the quarter. GDS Wealth Management owned about 0.12% of HealthEquity worth $9,569,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of HQY. Farther Finance Advisors LLC raised its stake in HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after buying an additional 172 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in shares of HealthEquity during the 2nd quarter worth approximately $33,000. True Wealth Design LLC grew its holdings in shares of HealthEquity by 3,522.2% during the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after acquiring an additional 317 shares during the period. Cullen Frost Bankers Inc. raised its position in shares of HealthEquity by 172.3% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after acquiring an additional 224 shares in the last quarter. Finally, Allworth Financial LP raised its position in shares of HealthEquity by 283.1% in the 2nd quarter. Allworth Financial LP now owns 747 shares of the company’s stock worth $78,000 after acquiring an additional 552 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president owned 73,979 shares in the company, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 13,959 shares of company stock valued at $1,344,957 over the last quarter. Company insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research note on Monday, January 19th. JPMorgan Chase & Co. upped their target price on shares of HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. JMP Securities set a $122.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. Barrington Research reissued an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research report on Thursday, December 4th. Finally, Citigroup restated an “outperform” rating on shares of HealthEquity in a report on Thursday, December 4th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $119.60.

HealthEquity Price Performance

Shares of HQY opened at $84.11 on Friday. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The company has a market capitalization of $7.19 billion, a P/E ratio of 38.58, a price-to-earnings-growth ratio of 1.22 and a beta of 0.20. The firm has a 50 day moving average of $94.62 and a 200 day moving average of $93.97. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.90 by $0.11. The business had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company’s revenue was up 7.2% compared to the same quarter last year. During the same period last year, the business posted $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.